CAR T-cell Therapy Impresses in Multiple Myeloma [News in Brief]

Phase I trial detects responses in 81% of patients with relapsed or refractory disease.

from Cancer via ola Kala on Inoreader http://ift.tt/2AS38sV
via IFTTT